E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
Start Date
8/8/2024
Completion Date
3/1/2027
Summary
The purpose of this an open-label, randomized controlled trial study is to compare the effectiveness of electronic cigarettes (e-cigarettes/e-cigs) versus telehealth motivational counseling with combination nicotine replacement therapy (NRT) + telehealth counseling on combustible cigarettes smoking reduction among persons with opioid use disorder (OUD) in methadone and buprenorphine treatment programs (opioid use disorder treatment programs (OUDTP)). OUDTP patients are a population with exceptionally high combustible cigarettes smoking burden and yet limited success in achieving meaningful clinical outcomes in tobacco treatment. If effective, electronic cigarettes would provide an additional tool for tobacco harm reduction among this difficult-to-treat vulnerable population.
Eligibility Criteria
Age Range: 21 years to 75 years
Interventions
Telehealth Motivational Counseling
Nicotine Replacement Product
National Institute on Drug Abuse (NIDA) Standardized Research Electronic Cigarette (SREC).
Conditions
Locations
NYU Langone Health
New York, New York 10016
United States
Albert Einstein College of Medicine
The Bronx, New York 10461
United States